vTv Therapeutics (VTVT) Operating Leases (2019 - 2025)

vTv Therapeutics has disclosed Operating Leases across 7 years of filings, most recently posting $125000.0 for Q1 2025.

• In Q1 2025, Operating Leases fell 58.05% year-over-year to $125000.0; the TTM figure through Mar 2025 stood at $125000.0 (down 58.05% YoY), while the FY2024 annual figure was $169000.0, changed 0.0% from the prior year.
• Operating Leases came in at $125000.0 for Q1 2025 at vTv Therapeutics, down from $169000.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $633000.0 in Q1 2021 to a low of $125000.0 in Q1 2025.
• Average Operating Leases over 5 years is $390470.6, with a median of $417000.0 recorded in 2023.
• Year-over-year, Operating Leases rose 2.95% in 2023 and tumbled 58.05% in 2025.
• Over 5 years, Operating Leases stood at $492000.0 in 2021, then plunged by 31.3% to $338000.0 in 2022, then plunged by 50.0% to $169000.0 in 2023, then changed by 0.0% to $169000.0 in 2024, then declined by 26.04% to $125000.0 in 2025.
• Per Business Quant data, the three most recent Operating Leases figures were $125000.0 in Q1 2025, $169000.0 in Q4 2024, and $213000.0 in Q3 2024.